Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 37, Issue 9, Pages -
Publisher
Wiley
Online
2023-08-19
DOI
10.1096/fj.202300980r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
- (2022) Xingkang Jiang et al. Frontiers in Oncology
- Cancer treatment and survivorship statistics, 2022
- (2022) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis
- (2022) Jinfei Li et al. Frontiers in Oncology
- Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis
- (2022) Kunping Li et al. APOPTOSIS
- Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor‐promoted inflammatory responses and prostate cancer progression
- (2022) An‐Ning Zhao et al. FASEB JOURNAL
- Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
- (2022) Liang Jin et al. Frontiers in Immunology
- Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy
- (2022) Jiling Feng et al. CANCER LETTERS
- Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
- (2021) Yang Yu et al. Cell and Bioscience
- Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth
- (2021) Mariachiara Buccarelli et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
- (2021) Wei Gao et al. Molecular Oncology
- Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma
- (2021) Kai Zhang et al. CANCER LETTERS
- NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway
- (2020) Shengjun Luo et al. EXPERIMENTAL CELL RESEARCH
- Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer
- (2020) Lisanne Mout et al. BRITISH JOURNAL OF CANCER
- SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway
- (2019) Mao Zhang et al. Cell Death & Disease
- Pyroptosis: A new frontier in cancer
- (2019) Yuan Fang et al. BIOMEDICINE & PHARMACOTHERAPY
- FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy
- (2019) Jian-zhong Lin et al. CANCER LETTERS
- MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
- (2018) Min-Ho Lee et al. Autophagy
- Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease
- (2018) Elizabeth A Rowland et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
- (2018) Jin Zeng et al. Theranostics
- Thymoquinone inhibits the metastasis of RCC cells by inducing autophagy via AMPK/mTOR signaling pathway
- (2018) Yujiao Zhang et al. CANCER SCIENCE
- Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
- (2018) Zhan Yang et al. ONCOGENE
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
- (2017) Zhan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) V. De Rosa et al. CLINICAL CANCER RESEARCH
- Targeting copper in cancer therapy: ‘Copper That Cancer’
- (2015) Delphine Denoyer et al. Metallomics
- Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer
- (2015) HAIQIU LIAO et al. ONCOLOGY REPORTS
- 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
- (2015) Corti Denise et al. Oncotarget
- HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
- (2014) Banzhou Pan et al. Molecular Cancer
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis
- (2012) Motoko Sasaki et al. LIVER INTERNATIONAL
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
- (2012) Ronald K. Blackman et al. PLoS One
- Molecular Responses of Human Lung Epithelial Cells to the Toxicity of Copper Oxide Nanoparticles Inferred from Whole Genome Expression Analysis
- (2011) Nobutaka Hanagata et al. ACS Nano
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Selective Autophagy in Cancer Development and Therapy
- (2010) Ivan Dikic et al. CANCER RESEARCH
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search